← Leaderboards
Ryan H Kolb
University Of Florida
$911,047
Attributed
$911,047
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $371.9K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$911,047 · 2
By mechanism
K22$539,142 · 1
R01$371,905 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Weizhou Zhang$6,977,638
- Benjamin K Canales$1,369,540
- Shannon Elizabeth Boye$7,910,294
- Dietmar W Siemann$11,801,985
- Marguerite Hatch$8,759,200
Others in their field
Other Emerging Leaders on “Response”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$195,683,539
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
Research focus
ResponseTumor ProgressionMalignant NeoplasmsPre-Clinical ModelTissuesTumor MicroenvironmentEfficacy TestingMalignant Breast NeoplasmObesityPre-ClinicalSignal TransductionTherapeutic TargetTumorTumor AngiogenesisAngptl4 GeneCellsAffectCancer TypeAntibodiesMouse ModelBreast Cancer ProgressionAngiogenesisAngiogenesis InhibitorsVascular Endothelial Growth Factors
Grant awards (4)
The role of Angiopoietin-like 4 in clear cell renal cell carcinoma and its therapeutic potential$371,905
R01 · FY2025 · CA · contact PI
Targeting ANGPTL4 in obesity-driven breast cancer progression$179,714
K22 · FY2022 · CA · contact PI
Targeting ANGPTL4 in obesity-driven breast cancer progression$179,714
K22 · FY2021 · CA · contact PI
Targeting ANGPTL4 in obesity-driven breast cancer progression$179,714
K22 · FY2020 · CA · contact PI